This Review discusses the current genetic and functional links between dysregulated and/or mutated RNA splicing factors and cancer, as well as the therapeutic opportunities presented by alterations in alternative splicing in cancer.
- Heidi Dvinge
- Eunhee Kim
- Robert K. Bradley